Whiskers-less HIV-protease: a possible way for HIV-1 deactivation

被引:6
作者
Dayer, Mohammad Reza [1 ]
Dayer, Mohammad Saaid [2 ]
机构
[1] Shahid Chamran Univ, Dept Biol, Fac Sci, Ahvaz, Iran
[2] Tarbiat Modares Univ, Dept Parasitol & Med Entomol, Tehran, Iran
关键词
HIV-1; protease; Inhibitors; Flap; Whisker truncation; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; BINDING-SITES; SIMULATIONS; INHIBITOR; MECHANISM; MONOMER; MUTANT; MODEL;
D O I
10.1186/1423-0127-20-67
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Among viral enzymes, the human HIV-1 protease comprises the most interesting target for drug discovery. There are increasing efforts focused on designing more effective inhibitors for HIV-1 protease in order to prevent viral replication in AIDS patients. The frequent and continuous mutation of HIV-1 protease gene creates a formidable obstacle for enzyme inhibition which could not be overcome by the traditional single drug therapy. Nowadays, in vitro and in silico studies of protease inhibition constitute an advanced field in biological researches. In this article, we tried to simulate protease-substrate complexes in different states; a native state and states with whiskers deleted from one and two subunits. Molecular dynamic simulations were carried out in a cubic box filled with explicit water at 37 degrees C and in 1atomsphere of pressure. Results: Our results showed that whisker truncation of protease subunits causes the dimer structure to decrease in compactness, disrupts substrate-binding site interactions and changes in flap status simultaneously. Conclusions: Based on our findings we claim that whisker truncation even when applied to a single subunit, threats dimer association which probably leads to enzyme inactivation. We may postulate that inserting a gene to express truncated protease inside infected cells can interfere with protease dimerization. The resulted proteases would presumably have a combination of native and truncated subunits in their structures which exert no enzyme activities as evidenced by the present work. Our finding may create a new field of research in HIV gene therapy for protease inhibition, circumventing problems of drug resistance.
引用
收藏
页数:8
相关论文
共 29 条
[1]   Characterization of the pH titration shifts of ribonuclease a by one- and two-dimensional nuclear magnetic resonance spectroscopy [J].
Baker, WR ;
Kintanar, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 327 (01) :189-199
[2]   HIV-1 protease: mechanism and drug discovery [J].
Brik, A ;
Wong, CH .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2003, 1 (01) :5-14
[3]   Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure [J].
Ceccherini-Silberstein, F ;
Erba, F ;
Gago, F ;
Bertoli, A ;
Forbici, F ;
Bellocchi, MC ;
Gori, C ;
d'Arrigo, R ;
Marcon, L ;
Balotta, C ;
Antinori, A ;
Monforte, AD ;
Perno, CF .
AIDS, 2004, 18 (12) :F11-F19
[4]  
Desiraju G. R., 1999, The Weak Hydrogen Bond
[5]   Disruption of the HIV-1 protease dimer with interface peptides:: Structural studies using NMR spectroscopy combined with [2-13C]-Trp selective labeling [J].
Frutos, Silvia ;
Rodriguez-Mias, Ricard A. ;
Madurga, Sergio ;
Collinet, Bruno ;
Reboud-Ravaux, Michele ;
Ludevid, Dolors ;
Giralt, Ernest .
BIOPOLYMERS, 2007, 88 (02) :164-173
[6]   HIV-1 protease flaps spontaneously close to the correct structure in simulations following manual placement of an inhibitor into the open state [J].
Hornak, V ;
Okur, A ;
Rizzo, RC ;
Simmerling, C .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (09) :2812-2813
[7]   Solution structure of the mature HIV-1 protease monomer - Insight into the tertiary fold and stability of a precursor [J].
Ishima, R ;
Torchia, DA ;
Lynch, SM ;
Gronenborn, AM ;
Louis, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) :43311-43319
[8]   Mutational and structural studies aimed at characterizing the monomer of HIV-1 protease and its precursor [J].
Ishima, Rieko ;
Torchia, Dennis A. ;
Louis, John M. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (23) :17190-17199
[9]   INHIBITION OF RETROVIRAL PROTEASE ACTIVITY BY AN ASPARTYL PROTEINASE-INHIBITOR [J].
KATOH, I ;
YASUNAGA, T ;
IKAWA, Y ;
YOSHINAKA, Y .
NATURE, 1987, 329 (6140) :654-656
[10]   ACTIVE HUMAN IMMUNODEFICIENCY VIRUS PROTEASE IS REQUIRED FOR VIRAL INFECTIVITY [J].
KOHL, NE ;
EMINI, EA ;
SCHLEIF, WA ;
DAVIS, LJ ;
HEIMBACH, JC ;
DIXON, RAF ;
SCOLNICK, EM ;
SIGAL, IS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4686-4690